This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Typically, patients hear a tapping sound and feel a tapping sensation in the head area during BrainsWay Deep TMS therapy session. To diminish the sound, the patient is provided with earplugs.
Some patients experience temporary, mild pain or discomfort in the area of the treatment site, which occurs during the treatment session. This typically occurs only during the first week of BrainsWay Deep TMS treatment. Other side effects may include muscle twitching and jaw pain.